KHP Capital’s Pfizer PFE Stock Holding History

KHP Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$269K	Sell	6,442 -738	-10%	-$28.4K	0.16%	57
2018 Q2	$247K	Hold	7,180	–	–	0.16%	53
2018 Q1	$242K	Sell	7,180 -565	-7%	-$19.4K	0.17%	54
2017 Q4	$266K	Buy	+7,745	New	+$264K	0.19%	56

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

KHP Capital's PFE Position: Q3 2018 in Review

KHP Capital reduced its Pfizer (PFE) stake by 10% in Q3 2018, selling an estimated $28.4K and leaving 6,442 shares worth $269K. The position accounts for 0.16% of the portfolio, ranked #57.

KHP Capital first reported a position in PFE in Q4 2017 and has held it in 4 quarters since. 2,256 funds tracked by Wall St. Rank hold PFE as of Q3 2018.

KHP Capital held 6,442 shares of Pfizer worth $269K as of Q3 2018.
KHP Capital sold 738 Pfizer shares in Q3 2018, an estimated $28.4K.
Pfizer made up 0.16% of KHP Capital's portfolio in Q3 2018, its #57 holding.
KHP Capital first reported a position in Pfizer in Q4 2017 and has held it in 4 quarters since.
2,256 funds tracked by Wall St. Rank held Pfizer as of Q3 2018.

Based on KHP Capital's 13F filing for Q3 2018, filed 8 Nov 2018.